Method and kit for rapidly screening gene editing positive monoclone based on qPCR (quantitative polymerase chain reaction)
By designing specific primers and probes based on qPCR, combined with single-cell lysis and dual-channel detection, the problems of inaccurate screening and insufficient throughput of traditional methods have been solved, enabling rapid and accurate screening of gene-edited positive monoclonal clones to meet clinical needs.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-06
- Publication Date
- 2026-04-14
AI Technical Summary
Traditional methods for screening gene-edited positive monoclonal clones are inaccurate and difficult to meet the needs of large-scale screening. Existing qPCR technology lacks specific detection solutions for gene-editing events.
Using a qPCR-based approach, specific primers and probes were designed, and combined with single-cell lysis and dual-channel detection, gene-editing-positive monoclonal clones were directly screened. Editing efficiency was determined by Ct value differences, and multiplex detection was performed using a matching kit.
It enables rapid and accurate screening of gene-edited positive monoclonal clones, meeting clinical requirements, and significantly improving screening throughput without relying on screening tags.
Smart Images

Figure CN121852520A_ABST